ClinicalTrials.govpublic full text
Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program
carcinoma, renal cell, nexavar, unresectable or advanced renal cell carcinoma, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 889508
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.